KA-34
N/A
Report date: 2023/02/25 20:20:41
NME
Base Information
Drug NameKA-34
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A
Develop Information
Active CompaniesThe Scripps Research Institute Inc
Inactive CompaniesCalifornia Institute For Biomedical Research
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A